The Recall Desk
Agency classClass IOur severity:SevereFDA (Drugs)·D-0084-2027·Announced 2026-10-28

Greenwich Rx Recalls Glutathione Injection Due to Microbial Contamination

Greenwich Rx is recalling 4,319 vials of Glutathione Injection due to microbial contamination of sterile products. The affected lots were distributed nationwide.

The agency’s classification

FDA (Drugs): Class I

Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 4/5 (Severe).

The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The recall is classified as FDA Class I due to microbial contamination of sterile products, which presents a reasonable probability of serious adverse health consequences. The source does not report any illnesses, injuries, or deaths.

Plain-English summary

Greenwich Rx is recalling 4,319 vials of Glutathione Injection (Glutathione-L, Ascorbic Acid, Sodium Hydroxide, Bacteriostatic Water), 200 mg/mL, 10 mL multi-dose vial. The recall is due to microbial contamination of sterile products.

The affected product is prescription-only and intended for subcutaneous use. The recall covers specific lots with expiration dates ranging from October 2026 to November 2026. The product was distributed nationwide in the United States.

Consumers and healthcare providers should stop using the affected product and contact their healthcare provider or the recalling firm for further instructions.

The recalled product

Product
Glutathione Injection (Glutathione-L, Ascorbic Acid, Sodium Hydroxide, Bacteriostatic Water), 200 mg/mL, 10 mL multi-dose vial, Rx only, Subcutaneous Only, Greenwich Rx.
Manufacturer
Greenwich Rx
Category
Drug — Injection
Hazard
Affected units
4,319

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (20)

  • Lot # 0060-062426-1
  • BUD: 10/02/2026
  • Lot # 0060-062726-1
  • BUD: 10/05/2026
  • Lot # 0060-070926-1
  • BUD: 10/17/2026
  • Lot # 0060-071426-1
  • BUD: 10/22/2026
  • Lot #0060-071426-2
  • Lot # 0060-072026-1
  • BUD: 10/28/2026
  • Lot # 0060-072726-1
  • BUD: 11/04/2026
  • Lot #0060-072926-1
  • BUD: 11/06/2026
  • Lot # 0060-073126-1
  • BUD: 11/08/2026
  • Lot # 0060-080426-1
  • BUD: 11/12/2026
  • Lot #: 0060-080526-1

Distribution

Distributed nationwide across the United States.

Related recalls

Same hazard · microbial contamination

See all →